Unknown PHASE4 INTERVENTIONAL 2-arm NCT01052025

Curcumin Therapy in Patients With Impaired Glucose Tolerance and Insulin Resistance

Antiatherogenic and Antimetabolic Effect of Curcumin Therapy in the Prevention and Delay of Type 2 Diabetic in Patients With Impaired Glucose Tolerance and Insulin Resistance

Sponsor: Ministry of Health, Thailand

Conditions Cardiovascular Risk Insulin Resistance Pre-diabetes Type 2 Diabetes

Interventions Curcumin

Updated 4 times since 2017 Last updated: Jan 19, 2010 Started: Aug 31, 2009 Primary completion: Mar 31, 2010 Completion: Apr 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Cardiovascular Risk and Insulin Resistance and is currently ongoing. Ministry of Health, Thailand leads this study, which shows 4 recorded versions since 2009 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE4

First recorded

Aug 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ministry of Health, Thailand
Srinakharinwirot University

Data source: Srinakharinwirot University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ongkarak, Thailand